FTC Sues Drug Companies for Unlawfully Conspiring to Delay the Sale of Generic AndroGel Until 2015

The Federal Trade Commission has filed a complaint in federal district court challenging agreements in which Solvay Pharmaceuticals, Inc. paid generic drug makers Watson Pharmaceuticals, Inc. and Par Pharmaceutical Companies, Inc. to delay generic competition to Solvay’s branded testosterone-replacement drug AndroGel, a prescription pharmaceutical with annual sales of more than $400 million. “At a time […]

FTC Sues Promoters of Bogus Fuel Efficiency Device

At the request of the Federal Trade Commission, a federal court has temporarily halted the deceptive advertising campaign and frozen the assets of an operation claiming its device can boost automobile gas mileage by at least 50 percent and “turn any vehicle into a hybrid.” The Commission is seeking a permanent ban on the ads […]

FTC Sues Promoters of Bogus Fuel Efficiency Device

At the request of the Federal Trade Commission, a federal court has temporarily halted the deceptive advertising campaign and frozen the assets of an operation claiming its device can boost automobile gas mileage by at least 50 percent and “turn any vehicle into a hybrid.” The Commission is seeking a permanent ban on the ads […]